2019
DOI: 10.1111/cbdd.13606
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of novel PC‐PLC activity inhibitors

Abstract: Phosphatidylcholine‐specific phospholipase C (PC‐PLC) is one of the important members of phospholipase family which is capable of specifically hydrolyzing the third phosphate linker of glycerophospholipid molecules, releasing phosphocholine and diacylglycerols (DAG). It is a crucial virulence factor of bacteria contributed to cell‐to‐cell spread and leading multiple diseases in mammals. Moreover, PC‐PLC has a wide range of biological functions and involves in various cell signaling pathway, including apoptosis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…PI‐PLC and phosphatidylcholine‐specific phospholipase C exhibit hemolytic activity. PI‐PLC is a recognized virulence factor that contributes to infective diseases in mammals, leading to apoptosis, proliferation, differentiation, and metastasis (Zhao et al., 2020). Further, HlyI (or cereolysin O) belongs to the cholesterol‐dependent cytolysin family of proteins that are able to bind to cholesterol on the cell surface and form transmembrane pores during infection (Beecher et al., 2000).…”
Section: Bacillus Cereus Pathogenic Toolkit: Toxins and Virulence Factorsmentioning
confidence: 99%
“…PI‐PLC and phosphatidylcholine‐specific phospholipase C exhibit hemolytic activity. PI‐PLC is a recognized virulence factor that contributes to infective diseases in mammals, leading to apoptosis, proliferation, differentiation, and metastasis (Zhao et al., 2020). Further, HlyI (or cereolysin O) belongs to the cholesterol‐dependent cytolysin family of proteins that are able to bind to cholesterol on the cell surface and form transmembrane pores during infection (Beecher et al., 2000).…”
Section: Bacillus Cereus Pathogenic Toolkit: Toxins and Virulence Factorsmentioning
confidence: 99%
“…To test whether the increase in DAG, PA and PG upon CAY94 treatment comes from PC, one should specifically block PC-PLC activity in combination with CAY94. Although the PC-PLC activity has been known for years, the mammalian PC-PLC has not been purified and the gene sequence has not yet been resolved [57]. The only commercially available pharmacological inhibitor of PC-PLC (D609) has several off-target effects [58], including inhibition of sphingomyelin synthase at similar concentrations as used to inhibit PC-PLC [59], thus at this point, we are not able to test our hypothesis.…”
Section: Discussionmentioning
confidence: 93%
“…The process of LysoPC passing through phosphatidylcholine to generate DAG as well as PE to generate DAG was activated. PLC hydrolyzes phosphatidylcholine and PE to generate DAG, which is required for membrane phospholipid and storage lipid production [61,62]. Together, phosphatidylcholine shifted acrylamide -induced phosphatidylcholine to LysoPC production to storage from LysoPC to DAG by downregulating LCAT and PEMT, and upregulating PLCB1.…”
Section: Gene Expression Involved With Differential Metabolitesmentioning
confidence: 99%